Developing regulations for the Assisted Human Reproduction Act, Canada

Main Category: Fertility
Article Date: 09 Nov 2004 - 12:00 PDT

Current ratings for:
'Developing regulations for the Assisted Human Reproduction Act, Canada'

Patient / Public:not yet rated

Healthcare Prof:not yet rated


Health Canada launched national consultations today to develop the regulations of the Act Respecting Assisted Human Reproduction and Related Research (AHR Act).

The AHR Act, which became law on March 29, 2004, has three main policy objectives: to prohibit unacceptable activities, to protect the health and safety of Canadians who turn to assisted human reproduction procedures to help build their families, and to ensure that research involving the in vitro embryo is undertaken in a controlled environment.

"Regulations will be developed to support the Act," said Health Minister Ujjal Dosanjh. "Health Canada is undertaking extensive consultations to ensure that interested parties have an opportunity to present their views, concerns and recommendations. The objective is to develop effective regulations that reflect the intent of the Act and the values of Canadians."

The first round of consultations, beginning today in Ottawa, involves the development of regulations for Section 8 of the AHR Act, which requires that the written consent of donors be provided for the use of their reproductive material or in vitro embryos. Upcoming rounds of consultations will involve:

-- reimbursement of expenditures to egg and sperm donors and the surrogate mothers (Section 12);

-- the use of in vitro embryos for research (Section 10);

-- clinical and laboratory practices, including clinical trials (Section 10);

-- preimplantation genetic diagnosis (Section 10);

-- the handling of health reporting information that licensed AHR clinics must collect from donors and individuals undergoing AHR procedures (Sections 14-19);

-- requirements for AHR-related counselling (Section 14);

-- administration of licensing, inspection and enforcement activities.

The dates for these consultations will be communicated as the process unfolds at Health Canada's Assisted Human Reproduction Website.

The consultations will involve health professionals, individuals who have undergone AHR procedures, interested members of the general public and provincial and territorial governments. Health Canada will seek public input in a variety of forms, ranging from workshops and discussion groups to written feedback on consultation documents. Proposed regulations will be published for public comment and reviewed by both Houses of Parliament.

The AHR Act is one of the most comprehensive pieces of legislation of its kind in the world and it is expected to take three years to develop all the components of its regulatory framework. The regulations will be administered by a new Assisted Human Reproduction Agency of Canada, which will be separate from Health Canada but will report to the Minister of Health, who is accountable to Parliament for the AHR legislation.

Media Inquiries:

Paige Raymond Kovach
Health Canada
(613) 948-4629

Adčle Blanchard
Office of the Minister of Health
(613) 957-0200

Public Inquiries:
(613) 957-2991

Article adapted by Medical News Today from original press release.
Visit our fertility section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Raymond Kovach. "Developing regulations for the Assisted Human Reproduction Act, Canada." Medical News Today. MediLexicon, Intl., 9 Nov. 2004. Web.
25 May. 2012. <http://www.medicalnewstoday.com/releases/16113.php>

APA
Raymond Kovach. (2004, November 9). "Developing regulations for the Assisted Human Reproduction Act, Canada." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/16113.php.

Please note: If no author information is provided, the source is cited instead.



Add Your Opinion On This Article

'Developing regulations for the Assisted Human Reproduction Act, Canada'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Your Name:*
E-mail Address:*
Your Opinion Title:*
Opinion:*
This is to help prevent SPAM submissions. Please enter the words exactly as they appear, including capital letters and punctuation.*

* Fields marked with a * need to be filled in before you hit the submit button.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.


Fertility

Most Popular Articles



Follow Our Fertility News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Fertility Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »